Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,187 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07579065Recruiting
Care Plan Support After Blood Cancer Stem Cell Transplant
This study tests whether a personalized care plan helps blood cancer patients and their caregivers manage life after stem cell transplant. Researchers want to see if this plan makes recovery smoother and improves quality of life.
Reggio EmiliaAges 18 years+ - NCT07583563Recruiting
Observational study of octreotide depot injections for acromegaly
This study watches how patients with acromegaly respond to octreotide, a medication given as injections under the skin. Researchers will collect information about how well the treatment works and any side effects you experience.
AachenAges 18 years+ - NCT07584954RecruitingPhase 1
Testing a new cancer immunotherapy in advanced solid tumors
This Phase 1 trial tests a new drug called IUAb190708 designed to help your immune system fight advanced or recurrent solid cancers. The study will evaluate its safety, how your body handles it, and whether it works against your tumor.
Fuzhou, FujianAges 18–75 - NCT07582809Recruiting
Digital therapy app for long-term insomnia relief
This study tests a smartphone app called BELL-001 that delivers digital therapy to help people with insomnia sleep better. It looks at how safe and effective the app is over a long period, and may offer an alternative to sleep medications.
IncheonAges 19–75 - NCT07582133RecruitingPhase 2
Long-term safety study of HRS-5965 for IgA kidney disease
This study follows up on patients who participated in a previous trial (HRS-5965-305) testing a drug called HRS-5965 for IgA nephropathy, a kidney disease where the immune system damages the kidneys. Researchers want to check if the drug continues to be safe and well-tolerated over a longer period.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07580716RecruitingPhase 2
Knee Injection Treatment for Moderate Osteoarthritis
This study tests a new cell-based injection (Allocetra) directly into the knee joint for people with moderate osteoarthritis who haven't benefited from other treatments. The goal is to reduce pain and improve knee function.
Longwood, FloridaAges 64 years+ - NCT07585097Recruiting
Long-term Safety Study of Odevixibat for Alagille Syndrome
This study follows patients with Alagille syndrome who are taking odevixibat to see how safe the medicine is over time. Alagille syndrome is a rare liver disease that affects bile flow, and odevixibat is a treatment that may help reduce itching and improve liver function.
BronAges 6 months+ - NCT07582315RecruitingPhase 3
BL-B01D1 for advanced biliary tract cancer after prior treatments
This study tests a new drug called BL-B01D1 against standard treatment options for patients with advanced biliary tract cancer (cancer of the bile ducts) that has stopped responding to platinum chemotherapy and immunotherapy. The drug is designed to target and destroy cancer cells more effectively.
Beijing, Beijing MunicipalityAges 18–75 - NCT07581184RecruitingPhase 1
Targeted Radioactive Therapy for Advanced Prostate Cancer
This Phase 1 trial tests a new radioactive treatment called [225Ac]Ac-AKY-2519 in men with advanced prostate cancer that has spread and stopped responding to hormone therapy. The drug carries radioactivity directly to cancer cells to try to shrink tumors and slow disease progression.
Irvine, CaliforniaAges 18 years+ - NCT07581951RecruitingPhase 3
Study of HSK31679 for people with MASH (liver scarring)
This trial tests a new medicine, HSK31679, for people with MASH (a type of fatty liver disease with inflammation and scarring). It aims to see if the drug can help improve liver health.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07579234RecruitingPhase 3
New drug F182112 for hard-to-treat multiple myeloma
This trial tests a new drug called F182112 against standard treatments for multiple myeloma that has stopped responding to previous therapies. The goal is to see if F182112 works better and is safe for patients whose cancer has become resistant to multiple drug classes.
TianjingAges 18 years+ - NCT06545708Recruiting
Music perception in children with SeLECTs epilepsy
This study looks at how children with a specific type of epilepsy (SeLECTs) and healthy children perceive music. It aims to understand if music perception is different in children with this condition.
Bron, BronAges 5–14 - NCT07582172RecruitingPhase 2
Stem Cell Transplant for Hard-to-Treat Blood Cancers in Older Adults
This trial tests a new combination of radiation and chemotherapy to prepare your body for a stem cell transplant from a matched donor. It's designed for older patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that hasn't responded well to standard treatments.
Duarte, CaliforniaAges 18 years+ - NCT07582913Recruiting
Manual vs. Automatic Breathing Support During Surgery in Older Adults
This study compares two ways of helping you breathe during anesthesia for surgery: one controlled by an anesthesiologist by hand, and one using an automatic machine. Researchers want to see which method works better and is safer for patients 65 and older.
Ankara, ÇankayaAges 65 years+ - NCT07580443Recruiting
Quality of Life After Open Surgery for Complex Aortic Aneurysms
This study follows patients who have had open surgery to repair complex abdominal aortic aneurysms—bulges in the main blood vessel in the belly. Researchers will ask you about your quality of life after surgery to understand how well people recover and feel.
LucerneAges 18 years+ - NCT07582276Recruiting
Bone health in men with severe hemophilia a on two treatments
This study looks at how two different hemophilia A treatments affect bone health over time. It tests if one medicine is better at keeping bones strong than the other.
Little Rock, ArkansasAges 30–50 - NCT07583160Enrolling by invitationPhase 1
YS247 Vaccine for Advanced Prostate Cancer
This trial tests a personalized cancer vaccine (YS247) designed to train your immune system to recognize and fight your prostate cancer. It may help slow or stop cancer growth in men whose cancer has spread and stopped responding to standard hormone treatments.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07584473Recruiting
Testing for Non-Celiac Wheat Sensitivity in Celiac Disease Relatives
This study investigates whether relatives of celiac disease patients who have digestive symptoms and other health concerns might have non-celiac wheat sensitivity or irritable bowel syndrome. Researchers will perform a small intestinal biopsy and dietary testing to understand the connection between wheat sensitivity and symptoms in this family group.
Palermo, PAAges 18 years+ - NCT07583251RecruitingPhase 1
Safety of a supplement for mild memory loss
This trial tests an oral supplement called gamma glutamylcysteine (GGC) in people with mild cognitive impairment (MCI) to see if it is safe and well-tolerated. It may help by supporting the body's natural defenses against cell damage.
Pittsburgh, PennsylvaniaAges 55–80 - NCT07584889RecruitingPhase 1/Phase 2
CAR-T Cell Therapy for Relapsed Blood Cancers
This trial tests a new type of immune cell therapy (CAR-T cells) designed to fight blood cancers that have come back or stopped responding to standard treatments. The therapy uses your own immune cells, which are modified in a lab to better recognize and attack cancer cells.
Shenzhen, Other (Non U.s.)Ages 18–75 - NCT07585500Recruiting
Virtual Reality to Help Recovery in ICU Patients
This study tests whether using virtual reality (VR) glasses can help patients recover better after spending time in the intensive care unit. The VR program is designed to help regain strength, movement, and mental function during recovery.
Porto, Porto DistrictAges 18 years+ - NCT07578532Recruiting
Nerve Stimulation for Overactive Bladder After Spinal Cord Injury
This trial tests two non-surgical treatments—magnetic and electrical nerve stimulation applied to the skin over the sacrum (base of spine)—to help control bladder overactivity in people with spinal cord injury. The goal is to reduce involuntary bladder contractions and improve bladder control.
AnkaraAges 18–65 - NCT07583927Enrolling by invitation
Blood Flow Monitoring During Stomach Cancer Surgery
This study examines how blood flow changes in tiny vessels under the tongue during a specific type of fluid management strategy in patients undergoing stomach cancer surgery. Researchers hope this information may help improve surgical outcomes and patient safety.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07577700Recruiting
Blood flow imaging study during pulmonary surgery
This study uses a special imaging technique called electrical impedance tomography (EIT) to measure how blood flows through your lungs during surgery for chronic thromboembolic pulmonary hypertension. The goal is to better understand how this imaging tool works and improve outcomes for patients having this procedure.
São Paulo, São PauloAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,187 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.